Oriel Therapeutics Inc.

Alternative versions and formulations of tough-to-copy products took center stage in US FDA's review and approval activity as FDA approved Adamis Pharmaceuticals Corp. 's epinephrine pre-filled syr

Alternative versions and formulations of tough-to-copy products took center stage in US FDA's review and approval activity as FDA approved Adamis Pharmaceuticals Corp. 's epinephrine pre-filled syr

In Vitro Diagnostics Alliances

Reformulating, repurposing and realizing the unfulfilled potential of drugs that already exist. Here's a business proposition for you. It's going to take from 10-15 years to get each product to market